[Report] The Obstetrics/Gynecology Hormone & Contraceptive Market: Opportunities for Growth, Customer Retention & Increased Efficiency TOC

1.1 Ob/Gyn Demographics
- a. Number of years Ob/Gyns have been in practice
- b. % of total working hours Ob/Gyns spend at the office (vs. hospital)
- c. Obstetrician & Gynecologist gender
1.2 Procedures & Trends
- a. # of featured types of surgical procedures performed per month (i.e. myomectomy, tubal ligation, global endometrial ablation, etc.)
- b. % of feature surgical procedures performed at various sites of care (hospital, surgery center, office, etc.)
- c. Surgical procedural trends (expected trend for each featured surgical procedure)
1.3 The AUB Patient Profile
- a. # of patients seen in a typical month
- b. % of patients seen for AUB/DUB
- c. % of AUB patients seen for various conditions
- d. % of AUB patients that receive various treatments
- e. AUB Treatment Flow Chart
- f. Trend in patients electing surgical procedures for AUB
- g. % of AUB patients previously treated by another Ob/Gyn
- h. AUB patients age
- i. AUB patients ethnicity
1.4 Birth Control Patients & Treatments
- a. % of total patients seen for birth control
- b. % of patients that receive various types of birth control treatments
- c. Birth Control Treatment Flow Chart
- d. % of birth control patients that request a specific type of birth control

2.1 Pharmaceutical Sales Representatives
- a. What type of sales rep contact do Ob/Gyns consider to be an actual visit?
- b. How many total sales rep visits to Ob/Gyns receive per month?
- c. Frequency of sales rep visits for each featured pharmaceutical company
- d. Quality of information presented during featured companies' sales rep visits
- e. Sales Force - relative performance positioning chart (for featured companies)
- f. How often do Ob/Gyns prefer to receive sales rep visits?
2.2 Professional Medical Education
- a. How many company-sponsored Prof Ed events do Ob/Gyns attend per year?
- b. Frequency of professional education attendance for each featured company
- c. Perceived quality of each companies' professional education events
- d. Professional education - derived z-scores (for each featured company)
- e. Prof Ed - relative performance positioning chart (for featured companies)
2.3 Marketing and Information Sources
- a. How to Ob/Gyns prefer to learn about new products?
- b. How to Ob/Gyns prefer to learn about new methods, techniques, treatments?
- c. How to Ob/Gyns market their practices?
- d. Number of hours Ob/Gyns spend on internet & reading medical journals for professional purposes
2.3 Ob/Gyn Attitudes
- a. Ob/Gyns' attitudes on various product statements

3.1 Importance
- a. Relative importance of considerations that drive product selection
- b. Relative importance of considerations (90% confidence intervals)
3.2 Experience & Associations
- a. Awareness and experience with featured pharmaceutical companies
- b. Top of mind products associated with featured manufacturers
- c. Top of mind manufacturer associated with featured considerations
3.3 Performance
- a. Performance ratings on various considerations (each featured company is measured)
- b. Performance ratings - standardized by column/consideration
- c. Performance ratings standardized by row/manufacturer
- d. Importance/Performance Gap Analysis (for each featured company)
- e. Relative Competitive Positioning Quadrant Chart (includes all featured companies)

The Obstetrics/Gynecology Hormone & Contraceptive Market: Opportunities for Growth, Customer Retention & Increased Efficiency